Your browser doesn't support javascript.
loading
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing.
Li, Bowen; Manan, Rajith Singh; Liang, Shun-Qing; Gordon, Akiva; Jiang, Allen; Varley, Andrew; Gao, Guangping; Langer, Robert; Xue, Wen; Anderson, Daniel.
Afiliación
  • Li B; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Manan RS; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Liang SQ; Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
  • Gordon A; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
  • Jiang A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Varley A; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Gao G; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.
  • Langer R; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Xue W; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Anderson D; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Biotechnol ; 41(10): 1410-1415, 2023 Oct.
Article en En | MEDLINE | ID: mdl-36997680
ABSTRACT
The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for messenger RNA and CRISPR-Cas9 gene editors. Lead lipid nanoparticles are amenable for repeated intratracheal dosing and could achieve efficient gene editing in lung epithelium, providing avenues for gene therapy of congenital lung diseases.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos